Daiju TAO, Peng CHEN, Yuqing LI, Linyi CHEN, Renhua YANG, Bo HE, Zhiqiang SHEN. Protective Effect of Corilagin on OX-LDL-Induced HUVECs Cell Damage and Its Impact on the Expression of the MyD88 Signaling Pathway[J]. Journal of Kunming Medical University, 2023, 44(10): 18-25. doi: 10.12259/j.issn.2095-610X.S20231019
Citation: Daiju TAO, Peng CHEN, Yuqing LI, Linyi CHEN, Renhua YANG, Bo HE, Zhiqiang SHEN. Protective Effect of Corilagin on OX-LDL-Induced HUVECs Cell Damage and Its Impact on the Expression of the MyD88 Signaling Pathway[J]. Journal of Kunming Medical University, 2023, 44(10): 18-25. doi: 10.12259/j.issn.2095-610X.S20231019

Protective Effect of Corilagin on OX-LDL-Induced HUVECs Cell Damage and Its Impact on the Expression of the MyD88 Signaling Pathway

doi: 10.12259/j.issn.2095-610X.S20231019
  • Received Date: 2023-05-31
    Available Online: 2023-09-07
  • Publish Date: 2023-10-25
  •   Objective  To investigate the protective effects of different concentrations and durations of corilagin treatment on oxidative low-density lipoprotein (ox-LDL)-induced damage in human umbilical vein endothelial cells (HUVECs), as well as its effects on the expression regulation of the MyD88 signaling pathway.   Methods  In vitro cultured HUVECs were used to replicate the ox-LDL-induced damage model. Morphological and immunological methods were employed to identify HUVECs cells. The MTT assay was used to determine the optimal conditions for replicating the ox-LDL-induced damage model in HUVECs. Cells were divided into different groups based on different treatments: normal group, model group, Corilagin (3.125, 6.25, 12.5, 25, 50 µmol/L) group, and positive control (VE 10 µmol/L, Simvastatin 1 µmol/L) group. The protective effect of corilagin on ox-LDL-induced damage in HUVECs was observed. Western blot and RT-qPCR methods were used to detect the expression changes of MyD88, P65, TNF-α, and MCP-1 in HUVECs cells.  Results  The cultured cells were confirmed as HUVECs by using morphological and immunological methods. The best condition for replicating ox-LDL-induced damage to HUVECs was 12 hours of treatment with 70 mg/L of ox-LDL. MTT results showed that compared with the ox-LDL group, the corilagin group had a significantly higher cell viability (P < 0.01). RT-qPCR and Western blot results showed that compared with the control group, the mRNA and protein expression of MyD88, P65, TNF-α, and MCP-1 were increased in the ox-LDL group (P < 0.01). Compared with the ox-LDL group, the mRNA and protein expression of MyD88, P65, TNF-α, and MCP-1 were decreased (P < 0.01) in the corilagin group and positive control group, and the corilagin group showed a dose-dependent downregulation of the mRNA and protein expression of MyD88, P65, TNF-α, and MCP-1.  Conclusion  With the increase of time and concentration, corilagin can significantly improve the cell viability of HUVECs induced by ox-LDL damage, and its protective effect is associated with the inhibition of the MyD88 signaling pathway.
  • [1]
    Shah P K. Inflammation,infection and atherosclerosis[J]. Trends Cardiovas Med,2019,29(8):468-472. doi: 10.1016/j.tcm.2019.01.004
    [2]
    Sharma T,Romeo F,Mehta J L. LOX-1: Implications in atherosclerosis and myocardial ischemia[J]. Excli J,2022,21(1):273-278.
    [3]
    Gao W,Liu H,Yuan J,et al. Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-α mediated NF-κB pathway[J]. J Cell Mol Med,2016,20(12):2318-2327. doi: 10.1111/jcmm.12923
    [4]
    Xiong X,Lu W,Zhang K,et al. Pterostilbene reduces endothelial cell apoptosis by regulation of the Nrf2-mediated TLR-4/MyD88/NF-κB pathway in a rat model of atherosclerosis[J]. Exp Ther Med,2020,20(3):2090-2098.
    [5]
    Chen T,Luo W,Wu G,et al. A novel MyD88 inhibitor LM9 prevents atherosclerosis by regulating inflammatory responses and oxidative stress in macrophages[J]. Toxicol Appl Pharm,2019,370(1):44-55.
    [6]
    Hosseini H,Li Y,Kanellakis P,et al. Toll-like receptor (TLR)4 and MyD88 are essential for atheroprotection by peritoneal B1a B cells[J]. J Am Heart Assoc,2016,5(11):e002947. doi: 10.1161/JAHA.115.002947
    [7]
    Basurto L,Gregory M A,Hernández S B,et al. Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women[J]. Exp Gerontol,2019,124(1):110624-110631.
    [8]
    Yu H,Cao H,Yu H. MicroRNA-98 inhibition accelerates the development of atherosclerosis via regulation of dysfunction of endothelial cell[J]. Clin Exp Hypertens,2023,45(1):2206068. doi: 10.1080/10641963.2023.2206068
    [9]
    夏欣,杨媛,李发靖,等. 柯里拉京的心脑血管保护作用及机制研究进展[J]. 医学综述,2022,28(2):229-234.
    [10]
    Tao Y,Zhang L,Yang R,et al. Corilagin ameliorates atherosclerosis by regulating MMP-1,-2,and -9 expression in vitro and in vivo[J]. Eur J Pharmacol,2021,906(1):174200-174210.
    [11]
    郭英,陈鹏,谢建平,等. Corilagin对血管内皮细胞的保护作用及LOX-1蛋白表达的影响[J]. 中成药,2012,34(1):151-154.
    [12]
    郭英,陈鹏,谢建平,等. Corilagin对HUVEC的保护作用及LOX-1 mRNA表达的影响[J]. 时珍国医国药,2011,22(10):2419-2421. doi: 10.3969/j.issn.1008-0805.2011.10.044
    [13]
    Gunta S P,O'keefe J H,O'keefe E L,et al. PCSK9 inhibitor,ezetimibe,and bempedoic acid: Evidence-based therapies for statin-intolerant patients[J]. Prog Cardiovasc Dis,2023,13(5):e068915.
    [14]
    Zhu K,Wang X,Weng Y,et al. Sulfated galactofucan from sargassum thunbergii attenuates atherosclerosis by suppressing inflammation via the TLR4/MyD88/NF-κB signaling pathway[J]. Cardiovasc Drug Ther,2022,10(1):7383-7397.
    [15]
    Park H J,Zhang Y,Georgescu S P,et al. Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis[J]. Stem Cell Rev,2006,2(2):93-102. doi: 10.1007/s12015-006-0015-x
  • Relative Articles

    [1] Yi YANG, Shen SHEN, Mengxia WAN, Yongbo ZHANG. Preoperative Fasting Triglyceride-glucose Index as a Predictor of Contralateral New Silent Ischemic Brain Lesions after Carotid Artery Stenting. Journal of Kunming Medical University, 2025, 46(2): 74-79.  doi: 10.12259/j.issn.2095-610X.S20250211
    [2] Aiyun WANG, Yuting WANG, Jing CAI, Ruoyan NI, Caiying LUO, Zhuo YU, Peng CHEN. The Role of Intestinal Flora and Its Metabolites in The Development of Atherosclerosis. Journal of Kunming Medical University, 2024, 45(12): 160-166.  doi: 10.12259/j.issn.2095-610X.S20241223
    [3] Li ZHANG, Yuting WANG, Jianing SHI, Dan YU, Renhua YANG, Zhiqiang SHEN, Jiang LONG, Peng CHEN. Network Pharmacology-based Analysis of the Anti-atherosclerosis Mechanism of Scutellarin and Experimental Validation in Vivo. Journal of Kunming Medical University, 2022, 43(8): 17-27.  doi: 10.12259/j.issn.2095-610X.S20220804
    [4] Yanlong LIU, Xuefeng GUANG, Xiaolong YIN, Hailong DAI. Effects of miR-125a-3p on Atherosclerotic Plaque, M1/M2 Macrophages, MMP-9 and VEGF. Journal of Kunming Medical University, 2022, 43(9): 1-6.  doi: 10.12259/j.issn.2095-610X.S20220915
    [5] Li ZHANG, Dan YU, Yu-ting WANG, Zhi-mei GOU, Ren-hua YANG, Bo HE, Zhi-qiang SHEN, Wen-ying CHAI, Peng CHEN. Effects of Scutellarin on Expressions of PKC and TNF-α in OX-LDL Injured RAW264.7 Cells in vitro. Journal of Kunming Medical University, 2021, 42(10): 1-7.  doi: 10.12259/j.issn.2095-610X.S20211040
    [6] Hai-long DAI, Nan WANG, Xiao-qing CHEN, Zhen-yi HE, Xiao-lan FENG, Xue-feng GUANG. Characteristics of Intestinal Microflora in Patients with Coronary Heart Disease. Journal of Kunming Medical University, 2020, 41(12): 36-41.  doi: 10.12259/j.issn.2095-610X.S20201213
    [7] Zhang Xiao Chao , Shen Zhi Qiang , Yang Ren Hua , Tang Chuan Jing , Bai Lin Ying , He Bo , Chen Peng , Yao Rong Cheng . Effects of Corilagin on Expression of CRP in OX-LDL Injured Macrophage Cells. Journal of Kunming Medical University, 2017, 38(08): 1-5.
    [8] Huang Sheng Hua , Li Xiao Xia , Lian Xi Yan , Chen Zi Yao , Zhao Jing Tao , Feng Zhi Jian . Influence of Uric Acid on Human Umbillical Vein Endothelial Cells under Oxidative Stress. Journal of Kunming Medical University, 2016, 37(12): 20-23.
    [9] Ke Ting Yu . . Journal of Kunming Medical University,
    [10] Lan Dan Feng . . Journal of Kunming Medical University,
    [11] Cao Rui . . Journal of Kunming Medical University,
    [12] Guan Bing . . Journal of Kunming Medical University,
    [13] Chen Li Ling . . Journal of Kunming Medical University,
    [14] Hu Yan Jie . . Journal of Kunming Medical University,
    [15] Nie Zhi . . Journal of Kunming Medical University,
    [16] Wang Ling . The Correlation between Lower Extremity Atherosclerosis and Bone Mineral Density in Type 2 Diabetes Mellitus Patients. Journal of Kunming Medical University,
    [17] . Evaluation of Atherosclerosis in Rheumatoid Arthritis Patients with High Lipid Levels by Ultrasonography. Journal of Kunming Medical University,
    [18] . Therapeutic Effect of PAS Combination Therapy on 40 Patients with Atherosclerosis. Journal of Kunming Medical University,
    [19] Deng Zi Yu . . Journal of Kunming Medical University,
    [20] Qiu Hong Mei . . Journal of Kunming Medical University,
  • Cited by

    Periodical cited type(3)

    1. 李泉洋,吴国泰,王瑞琼. 中药黄酮类成分干预多囊卵巢综合征下丘脑-垂体-卵巢轴分泌紊乱的研究进展. 中华中医药学刊. 2025(02): 146-152 .
    2. 危娟萍,钟柏林,危丽. 定坤丹与来曲唑治疗PCOS对患者超声指标及炎症因子影响. 中国医学创新. 2024(22): 133-137 .
    3. 康星星,贺文艳. 多囊卵巢综合征患者外周血IL-1β、NGF、AMH和FSH的表达及其与不孕的相关性. 医学临床研究. 2023(12): 1980-1982 .

    Other cited types(3)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04050100150200
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 26.0 %FULLTEXT: 26.0 %META: 73.5 %META: 73.5 %PDF: 0.5 %PDF: 0.5 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 4.0 %其他: 4.0 %China: 3.9 %China: 3.9 %上海: 6.6 %上海: 6.6 %东莞: 0.1 %东莞: 0.1 %临沂: 0.1 %临沂: 0.1 %北京: 39.8 %北京: 39.8 %哥伦布: 0.1 %哥伦布: 0.1 %天津: 0.1 %天津: 0.1 %安那罕: 0.0 %安那罕: 0.0 %宣城: 0.1 %宣城: 0.1 %延边: 0.0 %延边: 0.0 %张家口: 0.1 %张家口: 0.1 %抚顺: 0.1 %抚顺: 0.1 %无锡: 0.1 %无锡: 0.1 %昆明: 0.0 %昆明: 0.0 %杭州: 0.0 %杭州: 0.0 %深圳: 0.2 %深圳: 0.2 %濮阳: 0.1 %濮阳: 0.1 %芒廷维尤: 0.4 %芒廷维尤: 0.4 %菏泽: 0.2 %菏泽: 0.2 %西宁: 5.9 %西宁: 5.9 %诺沃克: 0.0 %诺沃克: 0.0 %贵阳: 0.3 %贵阳: 0.3 %郑州: 0.9 %郑州: 0.9 %驻马店: 36.4 %驻马店: 36.4 %其他China上海东莞临沂北京哥伦布天津安那罕宣城延边张家口抚顺无锡昆明杭州深圳濮阳芒廷维尤菏泽西宁诺沃克贵阳郑州驻马店

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(7)  / Tables(1)

    Article Metrics

    Article views (2495) PDF downloads(62) Cited by(6)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return